Normal values of insulin-like growth factor I and their clinical utility in adults

被引:38
作者
Strasburger, CJ [1 ]
Bidlingmaier, M [1 ]
Wu, ZD [1 ]
Morrison, KM [1 ]
机构
[1] Univ Munich, Dept Med, Neuroendocrine Unit, D-80336 Munich, Germany
关键词
acromegaly; acid-labile subunit; diagnosis; growth hormone deficiency; insulin-like growth factor I; insulin-like growth factor binding protein 3 monitoring; normative data; safety;
D O I
10.1159/000063484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration Of circulating insulin-like growth factor I (IGF-I) is a potential marker for growth hormone (GH) deficiency in adults. Indeed, researchers have shown that IGF-I levels are of greater diagnostic value than other possible markers, Such as IGF-binding protein 3 (IGFBP-3) and the acid-labile subunit (ALS). Accurate age-matched normative data are essential to give patient data diagnostic meaning. Such data are assay specific and must exclude those individuals with certain confounding medical conditions. Post-diagnosis, monitoring of IGF-I and IGFBP-3 levels can be used to assess the efficacy and safety of GH replacement therapy. Furthermore, IGF-I levels, and possibly ALS levels, can be used to aid the diagnosis and monitoring of acromegaly. For example, acromegaly can be excluded in patients with normal. IGF-I levels if liver failure and malnutrition/malabsorption are ruled out. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 21 条
[1]   Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults [J].
Aimaretti, G ;
Corneli, G ;
Razzore, P ;
Bellone, S ;
Baffoni, C ;
Bellone, J ;
Camanni, F ;
Ghigo, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (08) :506-511
[2]   Diagnostic value of the acid-labile subunit in acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 [J].
Arosio, M ;
Garrone, S ;
Bruzzi, P ;
Faglia, G ;
Minuto, F ;
Barreca, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1091-1098
[3]  
Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
[4]   The insulin-like growth factor-I system and hormone replacement therapy [J].
Cardim, HJP ;
Lopes, CMC ;
Giannella-Neto, D ;
da Fonseca, AM ;
Pinotti, JA .
FERTILITY AND STERILITY, 2001, 75 (02) :282-287
[5]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[6]   Does the GH-IGF axis play a role in cancer pathogenesis? [J].
Cohen, P ;
Clemmons, DR ;
Rosenfeld, RG .
GROWTH HORMONE & IGF RESEARCH, 2000, 10 (06) :297-305
[7]  
DEBOER H, 1994, LANCET, V343, P1645, DOI 10.1016/S0140-6736(94)93104-6
[8]   Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure [J].
Frystyk, J ;
Ivarsen, P ;
Skjærbæk, C ;
Flyvbjerg, A ;
Pedersen, EB ;
Orskov, H .
KIDNEY INTERNATIONAL, 1999, 56 (06) :2076-2084
[9]   New approach to the diagnosis of growth hormone deficiency in adults [J].
Ghigo, E ;
Aimaretti, G ;
Gianotti, L ;
Bellone, J ;
Arvat, E ;
Camanni, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (03) :352-356
[10]   Criteria for cure of acromegaly: A consensus statement [J].
Giustina, A ;
Barkan, A ;
Casanueva, FF ;
Cavagnini, F ;
Frohman, L ;
Ho, K ;
Veldhuis, J ;
Wass, J ;
Von Werder, K ;
Melmed, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :526-529